KA
Kairos Pharma, Ltd.
KAPA · AMEX
$1.80 -2.17% (-$0.04)
1M -27.76%
Market Cap $5.51M
P/E Ratio -
Div. Yield -
ROE 98.77%
Bulios Fair Price
$1.52
15.6% downside
Trenutna cena
$1.8
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica KAPA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 1.31x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 143.93%
ROE 98.77%
ROA 130.27%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 11.98x
Int. coverage N/A
Stability
50 /100
Moderate Beta 1.48x
EPS volatility 21.58%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o KAPA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John S. Yu
Employees
4
Headquarters
Los Angeles
Prihajajoči dogodki
13 NOV.
Earnings
Upcoming earnings report